资讯

The Health Ministry is closely monitoring two key issues following the tariffs imposed by the United States, particularly ...
Lexicon Pharmaceuticals, Inc.’s LXRX share price has surged by 7.25%, which has investors questioning if this is right time ...
The Health Ministry is closely monitoring two key issues following the tariffs imposed by United States (US) President Donald Trump, particularly those affecting medical devices and pharmaceutical ...
The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...
In addition to pharmaceuticals, Trump has also called for Section 232 investigations of semiconductors and critical minerals.
Trump’s planned pharmaceutical tariffs would raise costs by $51bn annually, report finds - Prices of medication and other ...
The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.
Trump also seems to be targeting China with his pharmaceutical tariff plans, saying that he hopes pharmaceutical companies will leave China as a result. What To Know. Trump said a ...
LONDON (Reuters) -A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, ...
Trump and his commerce secretary are threatening to make medications more expensive by slapping tariffs on them.